【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Tetanus Overview 9
Therapeutics Development 10
Pipeline Products for Tetanus – Overview 10
Pipeline Products for Tetanus – Comparative Analysis 11
Tetanus – Therapeutics under Development by Companies 12
Tetanus – Therapeutics under Investigation by Universities/Institutes 14
Tetanus – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Tetanus – Products under Development by Companies 19
Tetanus – Products under Investigation by Universities/Institutes 21
Tetanus – Companies Involved in Therapeutics Development 22
Beijing Minhai Biotechnology Co., Ltd 22
Bharat Biotech International Limited 23
Biological E. Limited 24
Daiichi Sankyo Company, Limited 25
Green Cross Corporation 26
Indian Immunologicals Limited 27
LG Life Sciences, Ltd. 28
Novartis AG 29
Panacea Biotec Limited 30
Prometheon Pharma, LLC 31
Sanofi 32
Sanofi Pasteur SA 33
Serum Institute of India Limited 34
Sinovac Biotech Ltd. 35
Zydus Cadila Healthcare Limited 36
Tetanus – Therapeutics Assessment 37
Assessment by Monotherapy Products 37
Assessment by Combination Products 38
Assessment by Target 39
Assessment by Route of Administration 41
Assessment by Molecule Type 43
Drug Profiles 45
(diphtheria + tetanus + pertussis (acelluar) + poliovirus (types 1, 2 ,3)) vaccine – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
(diphtheria + tetanus + pertussis (acellular) + hepatitis B + poliomyelitis + haemophilus influenza [serogroup B]) vaccine – Drug Profile 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
diphtheria + pertussis + tetanus + hepatitis [serotype B] + haemophilus influenza [serotype B] vaccine – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
diphtheria + pertussis + tetanus vaccine – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
diphtheria + pertussis + tetanus vaccine – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
diphtheria + tetanus + pertussis (acellular) vaccine – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
diphtheria + tetanus + pertussis (acellular) vaccine – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
diphtheria + tetanus + pertussis (whole cell) + haemophilus influenzae [type B] + polio (pentavalent) vaccine – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
diphtheria + tetanus + pertussis (whole cell) + hepatitis B + haemophilus influenzae [type B] + polio (hexavalent) vaccine – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
diphtheria + tetanus + pertussis (whole-cell) + haemophilus influenzae [serotype B] vaccine – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
diphtheria + tetanus + pertussis (whole-cell) + hepatitis B + haemophilus influenzae [serotype B] (pentavalent) vaccine – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
diphtheria + tetanus + pertussis (whole-cell) + hepatitis B + haemophilus influenzae [serotype B] vaccine – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
diphtheria + tetanus + pertussis (whole-cell) + poliomyelitis + haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] (7-valent) vaccine – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
diphtheria + tetanus+ pertussis (whole cell) vaccine – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + haemophilus influenzae [type B] (pentavalent) vaccine – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
diphtheria + tetanus+ pertussis (wholecell) + hepatitis [Type B] + poliomyelitis + haemophilus influenzae [type B] (hexavalent) vaccine – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
diphtheria + tetanus + pertussis (whole-cell) vaccine – Drug Profile 62
Product Description 62
Mechanism of Action 62
R&D Progress 62
diphtheria + tetanus vaccine – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
DTaP Vaccine – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
GC-1107 – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
GC-3111A – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
tetanus + diphtheria + pertussis (acellular) vaccine – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
tetanus vaccine – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
tetanus vaccine – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
tetanus vaccine – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
tetanus vaccine – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
VN-0103 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
Tetanus – Recent Pipeline Updates 74
Tetanus – Dormant Projects 75
Tetanus – Discontinued Products 77
Tetanus – Product Development Milestones 78
Featured News & Press Releases 78
Nov 14, 2014: Biological E To Supply Pentavalent Vaccine For Telangana State Immunization Program 78
Oct 20, 2014: US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine 78
Apr 01, 2014: Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel® Tdap Vaccine to Include Persons 10 Years of Age 79
Apr 22, 2013: Sanofi Obtains European Approval For Six-in-One Pediatric Vaccine Hexyon/Hexacima 79
Feb 22, 2013: Sanofi Pasteur Announces EMA’s CHMP Recommends Approval Of Hexyon/Hexacima Six-In-One Pediatric Vaccine 80
Oct 19, 2012: Sanofi Pasteur To Commercialize New 6-in-1 Paediatric Vaccine In European Markets 81
Jun 22, 2012: Sanofi Pasteur’s Hexaxim Receives Positive Opinion From European Medicines Agency 82
Jul 25, 2005: Sanofi pasteur Begins Shipping ADACEL Vaccine in the U.S. for Combined Protection against Tetanus, Diphtheria, and Pertussis 83
Jun 13, 2005: U.S. FDA Licenses sanofi pasteur’s ADACEL Vaccine for Combined Protection Against Tetanus, Diphtheria and Pertussis 83
Jun 10, 2005: Society for Adolescent Medicine Statement on the FDA Licensure of Adacel Vaccine 84
Appendix 85
Methodology 85
Coverage 85
Secondary Research 85
Primary Research 85
Expert Panel Validation 85
Contact Us 85
Disclaimer 86
【レポート販売概要】
■ タイトル：破傷風(Tetanus)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Tetanus - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6264IDB
■ 調査対象地域：グローバル
- 建築用塗料の世界市場：水性塗料、溶剤型塗料About Architectural Coatings Coatings are products used to protect a surface and/or enhance its appearance. Architectural coatings are applied to commercial and residential buildings to protect them from elements such as moisture, UV radiation, and microbes. Paints, primers, lacquers, varnishes, and stains are some of the major types of architectural coatings. These are formulated using various ty …
- Paris Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- 2012Paris Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Paris Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
- スペインの滅菌器市場見通し（～2021）Spain Sterilization Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Spain Sterilization Equipment Market Outlook to 2021", provides key market data on the Spain Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and Ultr …
- 有機酸の世界市場：酢酸、クエン酸、ギ酸、乳酸、プロピオン酸、フマル酸、アスコルビン酸、グルコン酸The organic acids market size is projected to reach USD 9.29 Billion by 2021, at a CAGR of around 6.0% from 2016 to 2021. The market is driven by its wide areas of application and R&D investments and technological innovations such as micro-encapsulation. The significant growth of the F&B industry and organic acids’ functionalities across various industries have also been driving the global organic …
- 卵加工の世界市場：乾燥卵、液状卵、凍結卵The egg processing market is growing with the increasing demand for egg products from the food industry. It is estimated that there are more than 1,000 egg processing facilities located globally. North America constituted the maximum number of egg processing facilities. Europe constituted more than 350 egg processing factories, with the maximum number in Italy. The number of liquid egg processing …
- 電子ペーパー用ディスプレイの世界市場2016-2020[Global E-Paper Display Market 2016-2020] Covering: This market research report includes a detailed segmentation of the global E-paper display market by application (E-book reader, mobile displays, public displays, wearable technology, and retail) and by technology (flat screen, curved screen, bendable screens, and foldable screens). It outlines the market shares for key regions such as the Americ …
- 世界の神経修復・神経再生市場：異種移植片、神経調節、手術などThe nerve repair and regeneration market was worth $4.1 billion in 2012 and is expected to grow at a CAGR of 11.5% in the next five years, primarily due to technological advancements and favorable reimbursement policies. The market is expected to witness a high growth in nerve grafting and neuromodulation segments, as they offer effective solutions for peripheral nerve repair and chronic pain, inc …
- リテイルレディパッケージの世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Retail-ready Packaging Market 2019-2023 Technavio recognizes the following companies as the key players in the global retail-ready packaging market: DS Smith, International Paper, Mondi, Smurfit Kappa, STI Group. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is th …
- 中国の3PL（サード・パーティー・ロジスティクス）市場2017-2021About Third Party Logistics Third-party logistics (3PL) is a business process, through which companies outsource logistics and distribution functions to a logistics service provider that specializes in transportation, warehousing, freight and forwarding, and others. 3PL is part of logistics services that specializes its logistics services according to the need of industry. Technavio’s analysts for …
- 屋内農業の世界市場展望2017-20276According to Stratistics MRC, the Global Indoor Farming market accounted for $106.6 billion in 2017 and is expected to reach $171.12 billion by 2026 growing at a CAGR of 5.4 % during the forecast period. Factors such as growing mechanisms in indoor farming and increasing focus on adopting innovative and efficient technologies are boosting the market growth. However, limitations on crop varieties a …
- ハンドドライヤーの世界市場：温風タイプ、ジェットエアタイプAbout Electric Hand Dryers Electric hand dryers are devices used to dry hands and are usually found in public washrooms. They either operate with a click or automatically using an infrared sensor. Electric hand dryers help in protecting the environment by saving trees from being used for paper towels and hence eliminating paper towel waste. They are more sanitary to use than paper and help maintai …
- 世界の食品生産市場におけるバイオテクノロジー動向（2014-2024）The biotechnology in food production market will reach US$101.96bn in 2014. Meeting rising global food needs will demand another era of widespread adoption of innovative, science-based biotechnologies in food production that consider environmental and ecological issues, nutrient deficiencies and other more complex issues. The food system already looks different than it was 20 or 30 years ago: peop …
- 保護包装の世界市場2016-2020About Insulated Packaging Insulated packaging offers protection from damage to industrial products, foods and beverages, pharmaceutical products, and equipment during shipping and storage. The global insulated packaging market is influenced by demographic trends, such as growing urbanization, population growth, an increase in international trading activities, and industrialization. The various typ …
- ヒトパピローマウイルス感染症(Human Papillomavirus Infections)：世界の治験レビュー2014年下半期版Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Human Papillomavirus Infections Global Clinical Trials Review, H2, 2014" provides data on the Human Papillomavirus Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Human Papillomavirus Infections. It includes …
- 澱粉誘導体の世界市場：マルトデキストリン、シクロデキストリン、グルコースシロップ、噴霧乾燥澱粉、加水分解物This report analyzes the starch derivatives market, in terms of region, function, type, and application. The starch derivatives market has grown exponentially in the last few years and this trend is projected to continue following the same trend until 2020. The market was valued at USD 45.74 million in 2014 and is projected to grow at a CAGR of 6.1% from 2015 to 2020. In terms of volume, the marke …
